Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 22, Issue 6, 1998, Pages 474-480

  Tsai, S C J ^a   ElSohly, M A ^b   Dubrovsky, T ^a   Twarowska, B ^a   Towt, J ^a   Salamone, S J ^a  

^a HOFFMANN LA ROCHE INC   (United States)

^b ElSohly Laboratories Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZOYLECGONINE; BISULFITE; COCAINE; MORPHINE; NITRITE; PHENCYCLIDINE; POTASSIUM; REAGENT; SODIUM NITRITE; TETRAHYDROCANNABINOLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG ABUSE; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; URINE; URINE PH;

CANNABIS SATIVA;

EID: 0031669985     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/22.6.474     Document Type: Article

References (26)

1. M. DeLancey and E.S. Kinkennon. Does Drug Testing Work? The Institute for a Drug-Free Workplace, Washington D.C., 1994.
2. T. Mieczkowski and K. Lersch. Drug testing in criminal justice. J. Natl. Inst. Justice 234: 9-15 (1997).
3. G. Hemphill. Drugs of abuse testing. Adv. Med. Lab. Professionals Oct: 10-14 (1995).
4. J.M. Walsh. Drug testing, a standard business practice. Empl. Assist. 10: 26-29 (1995).
5. American Management Association. Workplace Drug Testing and Drug Abuse Policies. New York, NY, 1995.
6. D.B. Fraser. Labs scramble to keep pace with schemes for defeating tests. Forensic Urine Drug Test. Aug: 1-6 (1997).
7. L.A. Broussard. Sample adulteration and other challenges. Forensic Urine Drug Test. Dec: 1-6 (1993).
8. S.D. Pearson, K.O. Ash, and F.M. Urry. Mechanism of false-negative urine cannabinoid immunoassay screens by Visine eye drops. Clin. Chem. 35: 636-638 (1989).
9. A. Warner. Interference of common household chemicals in immunoassay methods for drugs of abuse. Clin. Chem. 35: 648-651 (1989).
10. E. O'Connor, D. Ostheimer, and A.H.B. Wu. Limitations of forensic urine drug testing in methodology and by adulteration. AACC TDM/Tox. 14: 277-288 (1993).
11. S. George and R.A. Braithwaite. The effect of glutaraldehyde adulteration of urine specimens on Syva EMIT II drug-of-abuse assays. J. Anal. Toxicol. 20: 195-196 (1996).
12. 9-THC-9-COOH. J. Anal. Toxicol. 21: 240-242 (1997).
13. F.M. Urry, G. Komaromy-Hiller, B. Staley, D.K. Crockett, M. Kushnir, G. Nelson, and R.E. Struempler. Nitrite adulteration of workplace urine drug testing specimens I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration. J. Anal. Toxicol. 22: 89-95 (1998).
14. A.H.B. Wu and K. Rymut. The adulteration of urine drug testing samples with "Klear". AACC TDM Clin. Tox. Newsletter 12: 1-2 (1997).
15. F.M. Esposito. Problems associated with the confirmation of marijuana metabolites in urine specimens suspected of being adulterated with KLEAR (potassium nitrite). Proc. Am. Acad. Forensic Sci. 4: 249-250 (1998).
16. S.D. Ferrara, L. Tedeschi, G. Frison, G. Brusini, F. Castagna, B. Bernardelli, and D. Soregaroli. Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques. J. Anal. Toxicol. 18: 278-291 (1994).
17. D.A. Armbruster and J.M. Krolak. Screening for drugs of abuse with the Roche ONTRAK assays. J. Anal. Toxicol. 16: 172-175 (1992).
18. J. Towt, S.-C.J. Tsai, M.R. Hernandez, A.D. Klimov, C.V. Kravec, S.L. Rouse, H.S. Subuhi, B. Twarowska, and S.J. Salamone. ONTRAK TESTCUP: a novel, on-site, multi-analyte screen for the detection of abused drugs. J. Anal. Toxicol. 19: 504-510 (1995).
19. D.J. Crouch, M.L. Cheever, D.M. Andrenyak, D.J. Kuntz, and D.L. Loughmiller. A comparison of ONTRAK TESTCUP, Abuscreen ONTRAK, Abuscreen ONLINE and GC-MS urinalysis test results. J. Forensic Sci. 43: 35-40 (1998).
20. D.A. Armbruster. On-site assays bring drug testing to workplace-literally. Adv. Med. Lab. Professionals Oct: 6-8 (1996).
21. D.A. Armbruster. On-site on the rise. Med. Lab. Observer Apr: 40-44 (1997).
22. S.K. Strasinger. Urinalysis and Body Fluids, 3rd ed. F.A. Davis, Philadelphia, PA, 1994.
23. Abuscreen ONLINE for Cocaine; ONLINE for Opiate; ONLINE for THC (50 ng/mL); ONLINE for Amphetamine; and ONLINE for Phencyclidine: Package insert Rev. 3/96. Abuscreen ONLINE Cannabinoids Calibration Pack; Abuscreen ONLINE Calibration Pack: Package inserts, Rev. 4/95. Roche Diagnostic Systems, Inc., Somerville, NJ.
24. Abuscreen ONTRAK for Cocaine, ONTRAK for Morphine, ONTRAK for THC (50 ng/mL), ONTRAK for Amphetamine and ONTRAK for Phencyclidine, package inserts, Rev. 9/94; ONTRAK TESTCUP-5, package insert 3/97, Roche Diagnostic Systems, Inc., Somerville, NJ.
25. 9-THC acid metabolite in biological specimens. J. Anal. Toxicol. 16: 188-191 (1992).
26. A.D. Klimov and S.-C.J. Tsai. U.S. Patent application serial no. 08/385,300, 1995.